Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrating Buprenorphine Into the SFGH AIDS Program (Patient Evaluation Study)

NCT00263458 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00263458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00263458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrating Buprenorphine Into the SFGH AIDS Program (Patient Evaluation Study)
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2005
Completion date
June 30, 2009
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

buprenorphine, hiv, opioid dependence